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STUDY PROTOCOL Open Access
Evaluating a web- and telephone-based
personalised exercise intervention for
individuals living with metastatic prostate
cancer (ExerciseGuide): protocol for a pilot
randomised controlled trial
Holly E. L. Evans1, Cynthia C. Forbes2, Daniel A. Galvão3, Corneel Vandelanotte4, Robert U. Newton3,5, Gary Wittert1,
Suzanne Chambers6, Andrew D. Vincent1, Ganessan Kichenadasse7, Nicholas Brook8, Danielle Girard9 and
Camille E. Short1,10*
Abstract
Introduction: Preliminary research has shown the effectiveness of supervised exercise-based interventions in
alleviating sequela resulting from metastatic prostate cancer. Despite this, many individuals do not engage in
sufficient exercise to gain the benefits. There are many barriers, which limit the uptake of face-to-face exercise in
this population including lack of suitable facilities, remoteness, and access to experts, significant fatigue, urinary
incontinence and motivation. Technology-enabled interventions offer a distance-based alternative. This protocol
describes a pilot two-armed randomised controlled study that will investigate the feasibility and preliminary efficacy
of an online exercise and behavioural change tool (ExerciseGuide) amongst individuals with metastatic prostate
cancer.
Methods: Sixty-six participants with histologically diagnosed metastatic prostate cancer will be randomised into
either the 8-week intervention or a wait-list control. The intervention arm will have access to a tailored website,
remote supervision, and tele-coaching sessions to enhance support and adherence. Algorithms will individually
prescribe resistance and aerobic exercise based upon factors such as metastasis location, pain, fatigue, confidence
and current exercise levels. Behavioural change strategies and education on exercise benefits, safety and lifestyle are
also tailored through the website. The primary outcome will be intervention feasibility (safety, usability,
acceptability, and adherence). Secondary exploratory outcomes include changes in physical activity, quality of life,
sleep, and physical function. Outcomes will be measured at baseline and week 9.
(Continued on next page)
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Discussion: The study aims to determine the potential feasibility of an online remotely monitored exercise
intervention developed for individuals with metastatic prostate cancer. If feasible, this pilot intervention will inform
the design and implementation of further distance-based interventions.
Trial registration: ANZCTR, ACTRN12614001268639. Registered 10 December 2018, https://anzctr.org.au/
ACTRN12618001979246.aspx
Keywords: Exercise, Metastatic prostate cancer, Behavioural change, eHealth, Computer tailoring, Aerobic,
Resistance training
Introduction
Prostate cancer is one of the most common cancers
diagnosed amongst men worldwide [1]. Of those diag-
nosed, approximately 10–20% will present with meta-
static disease at the time of diagnosis, and an additional
one in five will progress from localised to metastatic dis-
ease despite treatment [2, 3]. Once prostate cancer has
metastasized, the 5-year survival rate drops from 95 to
36% [4]. Metastatic disease and the subsequent treat-
ments cause considerable physical and psychological
burden [5]. Androgen deprivation therapy, radiotherapy
and chemotherapy can result in increased fat mass, fa-
tigue and pain as well as reduced muscle mass, bone
mineral density, physical function and sexual function
[2, 6]. In addition, over 80% of individuals with advanced
prostate cancer will develop bone metastases, which can
result in significant bone pain, pathological fractures and
neurological impairments [5]. Individuals in this popula-
tion have also been found to exhibit higher levels of anx-
iety and depression than their age-matched peers,
including men diagnosed with localised prostate cancer
[7–9]. Given the high burden, there is a clear need to de-
velop interventions that help combat side effects, im-
prove physical function and reduce overall burden in
individuals with metastatic prostate cancer.
Research has demonstrated the beneficial effects from
physical activity and more specifically, structured exer-
cise interventions in individuals with prostate cancer
[10, 11]. Currently, it has been suggested that exercise
can play an important role in symptom management, re-
habilitation and long-term survival [5, 10, 11]. Whilst
the physiological mechanisms behind this are yet to be
elucidated, it is hypothesised that exercise improves im-
mune function, modulates circulating factors (such as
insulin and growth factors), reduces inflammation and
improves treatment efficacy [5]. However, until recently,
those with metastatic disease were discouraged from
structured exercise for fear of exacerbation of symptoms
or increased risk of skeletal-related events [12].
New evidence is now available to show that supervised
multi-modal exercise can be safe, feasible and clinically
relevant in individuals with metastatic prostate cancer
[12–15]. Cormie et al. were the first to show that resist-
ance training is both safe (no adverse events found) and
tolerable (attendance 83% and compliance 93%) in this
population using a pilot study [12]. Galvão et al. then
implemented a multi-modal (resistance, aerobic and
flexibility training) intervention and found significant
improvements in physical function (mean difference 3.2
points; 95% confidence interval (CI) = [0.4, 6.0]; P =
0.028) and muscular strength (mean difference of 6.6 kg
(95% CI = [0.6, 12.7]; P = 0.033)) after 12 weeks [14].
Currently, the Movember GAP4 INTERVAL trial is
examining overall survival in individuals completing a
vigorous-intensity face-to-face multi-modal exercise
programme [16].
Despite the mounting evidence regarding the benefits
of supervised multimodal exercise for this population,
many do not engage in sufficient physical activity to ob-
tain health benefits. Zopf et al. found that only 20% of
patients achieved 50–149 min per week of self-rated
moderate to vigorous aerobic activity, and 29% of pa-
tients achieved ≥ 150 min [17, 18]. This is despite evi-
dence that 92% of individuals with advanced cancer
being interested in becoming more active [19]. Barriers
to exercise in this population include general exercise
barriers such as the lack of suitable facilities, remoteness,
motivation and access to experts, as well as disease-
specific barriers such as significant fatigue, urinary
incontinence, mood, high levels of other medical com-
mitments and lack of education regarding exercise for
individuals with prostate cancer [8, 20]. It is currently
unknown how many Australian individuals with meta-
static prostate cancer receive individualised exercise
advice.
Home-based exercise programmes offer a feasible al-
ternative to counteract some of the obstacles to on-site
exercise interventions because they may be able to re-
duce location constraints, financial and time limitations
[21, 22]. However, current research indicates that these
interventions produce smaller effect sizes in cancer
populations on both quality of life and physical function
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when compared to face-to-face exercise [10, 23]. Lack of
supervision and personalised support, reduced interven-
tion adherence and limited individualisation are all pos-
sible causes of this discrepancy [10, 24, 25].
The use of technology in distance-based health care,
otherwise known as eHealth, may help to improve the
capacity of distance-based programmes. For example,
web-based platforms have the ability to prescribe and
demonstrate tailored exercise plans, provide tailored be-
havioural change advice, facilitate self-monitoring and
support communication with healthcare professionals.
Much of this can be achieved in an automated fashion
using computer-tailoring techniques, thus allowing for
personalization at a low-cost [26]. Reviews of digital
health interventions for behaviour change suggest that
some level of human support is important for efficacy
[27, 28]. E-Health interventions utilising some of these
techniques to support prostate, colorectal, breast and
leukaemia cancer populations have already been trialled
with good effects in terms of improved physical activity
levels and reduced sedentary behaviour [24, 29–32].
However, the extent to which these techniques are ac-
ceptable, safe and potentially effective for supporting in-
dividuals with metastatic prostate cancer, given their
unique needs and risk profile, is unknown. Our study
seeks to address this gap by conducting a pilot evalu-
ation of ExerciseGuide, a web-based and telephone sup-
ported personalised exercise intervention designed for
individuals living with metastatic prostate cancer.
The primary objective of the trial is to assess key areas
of uncertainty regarding the use of ExerciseGuide (and
other similar programmes) in future practice and re-
search, including issues relating to feasibility, safety and
potential for efficacy. Publication of this protocol aims
to ensure transparency around pre-specified criteria for
success, aid replication of study and intervention




This study is a two-arm pilot randomised control trial
with participants randomised into either the intervention
group (8 weeks) or a wait-list control group. Mixed
evaluation methods will be used, with main outcomes
assessed using questionnaires and accelerometers at
baseline and post-intervention, and via a qualitative
interview at post-intervention only. A sub-group of par-
ticipants will be invited to complete physical function
testing at baseline and post-intervention.
The trial has been prospectively registered on the Aus-
tralian New Zealand Clinical Trials Registry (http://
www.anzctr.org.au): ACTRN12614001268639 and ethical
clearance were obtained by the University of Adelaide
Research Ethics Committee (H-2018-153). To aid repli-
cation, study materials, such as the participant informa-
tion sheet and data request forms from physicians, are
available via the open science framework (https://osf.io/
jfmy2/). The reporting of the study protocol is in accord-
ance with the Standard Protocol Items: Recommenda-
tions for Interventional Trials (SPIRIT) guidelines [33].
The SPIRIT figure outlining the time procedure is
shown Fig. 1.
Pre-established criteria
Feasibility of conducting a larger-scale evaluation will be
interpreted based on the following:
1. The recruitment goal has been reached (66
participants in 10 months).
2. Behaviour change data are collected for ≥ 75% of
participants recruited within the study.
3. Physical functioning data (collected on a subset of
participants) can be collected for ≥ 75% of
participants that (a) reside within 30 km from a
study testing site and (b) are invited to complete
testing.
The success of the intervention will be interpreted
based on the following:
1. The acceptability of the intervention is satisfactory
(score of ≥ 20 on the client satisfaction
questionnaire) [34].
2. The system usability is satisfactory (score of ≥ 68
on the software usability scale) [35].
3. There is no grade 3+/life threatening or severe
adverse events attributed to participating in the
intervention using the Common Terminology
Criteria for Adverse Events V.5.0 grading criteria.
4. There is evidence of meaningful participation in
either aerobic activity and or resistance-based activ-
ity in the intervention group relative to the wait-list
control. As the exercise prescription will be perso-
nalised, it is difficult to specify an average cut-point;
however, we anticipate a between-group difference
of at least 30 min of aerobic activity and/or one ses-
sion of resistance training. This would be indicative
of behaviour change that is in line with the mini-
mum level of exercise progression prescribed in our
intervention and should also allow us to detect dif-
ferences in maintenance of activity (equivalent to
one session per week) amongst those that enter the
study already completing some exercise.
The trial team will determine if progression to a larger
scale evaluation is warranted based on the criteria and
will work together to revise aspects of the protocol if
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problem areas are identified (e.g. if recruitment is slow
the study may still progress if additional recruitment
sites can be secured). The process evaluation will be
used to inform improvements to the intervention if us-
ability, acceptability or potential for efficacy issues are
identified.
Study setting
This study is being conducted in Australia. Due to the
distance-based nature, participants can live anywhere in
the country providing they meet the eligibility criteria.
Recruitment began in February 2020 and will continue
for a minimum of 10months, unless the desired sample
size is reached beforehand.
Participants and screening
Participants are being recruited via a variety of
methods. This includes dissemination of study infor-
mation to potential participants within Australia via
intermediaries (e.g. urologists, oncologists and nurses
from the Southern Adelaide Local Health Network
and Central Adelaide Local Health Network). Recruit-
ment will also occur through the South Australian
Prostate Cancer Clinical Outcomes Collaborative
registry, Freemasons Foundation Centre for Men’s
Health recruitment registry, Prostate Cancer Founda-
tion Australia (e.g. Pathfinders recruitment registry
and support groups), social media advertisements (e.g.
on twitter and Facebook), and direct contact (e.g. pre-
sentations to consumer groups). Interested individuals
are referred to the project coordinator (HE) to con-
firm eligibility, obtain informed consent and clear-
ances and arrange outcome assessments. Figure 2
outlines the participant flow diagram.
To be eligible, participants must have been diagnosed
with metastatic prostate cancer (as confirmed by their
physician) and have medical clearance from their phys-
ician (General Practitioner, Medical Oncologist, Radi-
ation Oncologist or Urologist). Physicians are required
to provide details regarding the extent and location of
metastases. Participants also need to have access to a
computer with the internet, be able to read and write in
English and provide written consent prior to baseline
testing. Finally, to be eligible participants should not
already engage in two sessions of resistance-training and
60minutes of structured moderate-vigorous aerobic ex-
ercise per week. Participants meeting one target but not
the other will be eligible.
Patients will be deemed ineligible if they have any
absolute contraindications to performing moderate
physical activity (resistance, aerobic and flexibility) for
at least 20 min (in bouts of 5 min), up to 2 days of
the week. This includes no recent serious cardiovas-
cular events (within 12 months), unstable bone metas-
tases, spinal compressions or acute illness and
infection [36]. Participants will also be excluded from
Fig. 1 SPIRIT figure of enrolments, interventions and assessments
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the study if they have moderate to severe bone pain
(Common Terminology Criteria for Adverse Events
V.5.0 grading criteria).
Participant retention strategies will include flexible
scheduling for telehealth consultations, reminder calls/
texts and consistent study staff. Criteria for discon-
tinuing intervention include participant request and
worsening conditions which are absolute contraindica-
tions to exercise (including unstable bone metastasis,
spinal compression and significant cardiovascular
events). Concomitant care will be permitted during
the study and any changes in treatment will be
recorded.
Randomisation
Once baseline data have been collected, participants will
be randomised into the intervention group or the con-
trol group at a ratio of 1:1. The study statistician (AV)
will produce the random computer-generated number
sequence in random block sizes of length 2 and 4, and
will be blinded to identifying information. Stratification
will occur based on age (≤ 65 years, > 65 years of age)
and differences in physical function as determined by
the EORTC QLC-30 (≤ 80, > 80). This is to control for
potential confounders relating to age (including confi-
dence using technology) and physical capacity. Partici-
pants will not be blinded to the primary goal of the
Fig. 2 Study flow diagram
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project (evaluation of web-based tool in this population)




Development of the intervention (ExerciseGuide) was
guided by the Intervention Mapping protocol [37],
which involves a needs assessment, identification of de-
terminants of the desired intervention outcomes and the
selection of theory-based and evidence-informed strat-
egies to target key determinants or change objectives.
The process was undertaken predominantly by HE and
CES, in collaboration with consumer representatives,
hence drawing on expertise in exercise prescription, be-
haviour change and the lived experience of prostate can-
cer. An overview of the development process, including
original research conducted and theories considered is
described below.
In brief, a qualitative interview study (N = 18) was
completed to better understand the needs and prefer-
ences of individuals in this population. This was con-
ducted alongside a systematic review of online
interventions for prostate cancer patients to determine
feasibility, acceptability and efficacy, as well as factors as-
sociated with success (or failure) [38]. These studies
highlighted that online supportive care interventions are
acceptable in individuals with prostate cancer. Partici-
pants within the qualitative study stressed the import-
ance of individualised exercise prescription, the need for
evidence-based educational content, support and feed-
back to aid adherence. Importantly, participant’s accur-
acy of reporting metastasis location and extent was
mixed, indicating further reporting measures would be
required to ensure appropriate prescription.
The selection of theory to guide intervention develop-
ment was informed by our original research, and evi-
dence in the fields of exercise and health psychology
more broadly [39–44]. A summary of the theories used
and associated implications is provided in Supplemen-
tary Table 1. Of note, a variety of theories were consid-
ered necessary to draw upon based on the premise that
exercise behaviour is guided by dual processes, and that
for longer-term behaviour change to occur; it is neces-
sary not only to address social-cognitive determinants
like self-efficacy but also to address how people feel and
the extent to which their behaviour change process is
habit-forming in nature [41, 43]. Theory was also used
to inform the architecture of the intervention and the
provision of computer-tailored feedback (self-determin-
ation theory and elaboration likelihood model) [45, 46].
Once important determinants and potentially accept-
able and efficacious strategies were identified based on
the above research, a prototype of the intervention was
developed in collaboration with consumer advisors and
volunteers. This involved filming exercise videos and
drafting website content and tailoring algorithms. Fi-
nally, the prototype was tested and iteratively refined in
a lab-based usability and safety test (N = 11 patients with
metastatic prostate cancer), until the intervention was
considered ready for trial in the proposed study.
Intervention description
The intervention will use a tailored website, exercise
diary and tele-coaching sessions over a period of 8 weeks
to provide exercise and lifestyle support for men living
with metastatic prostate cancer. Participants can drop
out of the intervention at any time and concomitant care
is permitted at all times.
Tailored website The intervention group will be given
access to the tailored website (www.exerciseguide.org.au)
for a period of 8 weeks (Fig. 3). The tailored content, de-
livered via modules, will be adjusted based on individual
characteristics through an automated computer process.
This approach (known as computer-tailoring) leads to
the delivery of more personally relevant information,
which increases message safety and efficacy [21, 47, 48].
Modules include evidence-based information on the
safety and benefits of physical activity, an individually
tailored exercise programme, behaviour change informa-
tion, self-monitoring, lifestyle information and other re-
sources of use (Table 1). Based on the previous
qualitative work in this area, participants will receive ac-
cess to all modules as soon as they complete the initial
introduction module and are free to complete the mod-
ules in order of personal priority.
Web-based exercise prescription Participants are indi-
vidually prescribed an 8-week multi-modal (resistance,
aerobic and flexibility) programme based upon the con-
servative prescription used in Galvão et al. (Table 2) and
isometric spinal exercise prescription applied in Rief
et al. [14, 15]. Exercise prescription variables can be
autoregulated by re-completing module assessment
questions using the links on the homepage. The intensity
or volume of session regulated can be modified by par-
ticipants modifying their fatigue ratings, pain levels and
confidence. Resistance exercises which produce pain can
also be changed by adjusting the movement-based ques-
tions (e.g. Do you experience pain when you bend or
straighten your elbow whilst holding a heavy item?). Par-
ticipants are educated on autoregulation via the safety
and exercise plan modules and programme modification
through computer-tailoring is discussed in the initial
tele-coaching session).
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Resistance-based component There are twenty-seven
possible resistance exercises available for prescription
(Supplementary Table 2), which have been used in Gal-
vão et al. and Rief et al. [14, 15]. However, dependent on
the algorithm, participants will be prescribed between
three and eight exercises. Unpublished usability testing
on eleven men reported a median of six exercises pre-
scribed per person. Each resistance exercise will be ac-
companied by a video demonstration (see Fig. 4) and
written exercise instructions to aid both safety and effi-
cacy. Participants will be mailed four resistance exercise
bands of different loads, which match the resistance
bands used within the videos as well as a door anchor to
help them to complete the exercises prescribed. More-
over, participants with access to home-based or gym re-
sistance training equipment (e.g. dumbbells) will be
encouraged to replicate the exercises with their equip-
ment if possible. Eccentric and concentric phases are
performed over a period of 2 seconds each to reduce
peak forces transmitted to the skeleton [12–14].
Intensity will be prescribed individually using the
OMNI resistance exercise scale of perceived exertion
(Fig. 5) and will range between seven to eight out of ten
(moderate-vigorous intensity) as determined by current
fatigue levels and both resistance training experience
and confidence [50]. This variability has been built in to
help balance adherence with the stimulus needed to see
clinically relevant outcomes. A 12- to 8-repetition
maximum has been prescribed for two to three sets per
exercise (Table 3). Self-reported questions at the end of
week three will allow researchers to monitor compliance.
Participants unable to comply to at least 80% of the pre-
scription (based on total sessions completed and compli-
ance to volume prescribed) will be given a modified
prescription for the last five weeks (Supplementary Table
3) to ensure the participant does not increase repetitions
or sets too rapidly. To encourage progression, partici-
pants will be instructed to increase the resistance of the
upper and lower body exercises by self-assessed 5-10% if
the rate of perceived exertion standards were exceeded
in each exercise set completed [14].
Frequency of resistance training will be 2 days per
week for the first 3 weeks and then increased to three
sessions if the participant was able to adhere. Partici-
pants already completing one or more sessions per week
prior to the intervention starting will be required to
complete at least two sessions per week of the Exercise
Guide programme and will be encouraged to complete
more sessions of their own prescription if they wish.
Aerobic-based component Individuals with bone me-
tastases will be prescribed either stationary cycling,
water walking or walking. For individuals without bone
metastases, other modes such as conventional cycling,
rowing or cross trainers are also prescribed. Equipment
accessibility, metastasis location, pain and preference
Fig. 3 Screenshot of the Exercise Guide home page and one page of the My Exercise Plan module
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influence what mode is prescribed. For individuals cur-
rently completing two sessions or less a week, two ses-
sions a week will be prescribed for the first 3 weeks. If
individuals are completing three or more sessions, then
they will be prescribed three specific aerobic sessions.
Individuals are encouraged to complete extra aerobic
Table 1 Overview of tailored modules included in 8-week intervention (page 10)
Module title Module goal(s) Tailoring variable Mechanisms of
action
Getting started
(how to use this site)





Provide individualised exercise prescription to
participants.
The aerobic training component of the study is
based on metastases location, current aerobic
modes, current duration and frequency completed
and pain levels. Self-reported ability which includes
current fatigue levels, experience and confidence,
will also be taken into account (14).
Resistance exercise prescription is be tailored to
the individual based on metastasis location pain or
injury location, current fatigue levels and both
resistance training experience and confidence.
Favoured modes of exercise and access to






Progression of exercise prescription on current
exercise levels.
Current aerobic exercise levels (current duration
and frequency completed). Current resistance
training levels (session frequency and percentage
of sets and reps completed)
Repeated questions from My Exercise Plan (week 1-
3) with previous answers. Participants asked to re-






Help men to develop a deeper understanding of
the benefits of exercise, and how these benefits
accrue. Highlight benefits that are personally
relevant.
Strengthen intentions to participate in structured
exercise.
Health issues that may be improved through
exercise (e.g. fatigue, poor sleep, muscle weakness)










Provide men with tailored information regarding
safety implications to promote educational
empowerment. Provide an understanding of
when exercise should be terminated to avoid risk
of injury.
Cancer-specific considerations that may impact the
safety of exercise prescription; specifically, current
treatment/disease side effects (e.g., fatigue,
neuropathy) and treatments (e.g., chemotherapy,
androgen deprivation therapy). Co-morbidities (e.g.,









Facilitate self-monitoring of exercise behaviours
and exercise outcomes, with the aim of strength-
ening self-regulation.
Date, frequency of exercise, satisfaction with goal,
motivation, planning score, habit scores, perceived








Support the adoption and maintenance of
health-enhancing exercise behaviours.
Structured exercise programme status (interested
but not commenced, commenced but finding it
hard to adhere to, commenced and finding it easy
to adhere to), barrier self-efficacy, exercise planning










else can you do to
keep healthy?)
Increase health literacy regarding other lifestyle
factors that may impact on health and quality of
life besides structured exercise. Provide links to
further information. Provide men exhibiting high
distress with information on where to find help.
Current diet, sitting time, alcohol consumption,





Where else can I
get help?
Facilitate access to additional support needed in
order to improve lifestyle behaviours and quality
of life.
Topics of interest (diet, exercise, distress, sleep,
symptom management, clinical trials), preferred
forms of help (e.g. guidance from a professional,
booklets), and interest in advice specific to
Aboriginal or Torres Strait Islander people, people
who have English as a second language and/or
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sessions if they feel capable. In terms of duration of ses-
sions, participants will complete 2-3 sets of between 6
and 15min, with rest intervals ranging from 0 to 5 min
or 1 session of 30 min with no prescribed rest (Table 4).
Session duration and rest intervals will be based on what
activity duration the participant feels is feasible, if they
are currently meeting this level and an ability score
based on previous experience, levels of fatigue and confi-
dence for completing two sessions per week. Intensity
will be prescribed using the OMNI aerobic exercise scale
of perceived exertion [50]. Intensity will be prescribed
individually and will be between six and seven out of ten
(moderate intensity) as determined by current fatigue
levels and both experience and confidence.
Flexibility exercises will be prescribed based on previ-
ous work by Galvão et al. (see Table 2), which has been
shown to be safe. Static stretching will involve all major
muscle groups involved in the session held for 30-60 s
over a period of 2-4 sets and will be prescribed via pic-
torial and written instructions.
Tele-health coaching and monitoring of progress To
keep participants engaged in the programme and ensure
sufficient support, participants will also have access to
an accredited exercise physiologist (HE). The role of the
exercise physiologist will be to encourage uptake of the
8-week individually prescribed programme, provide feed-
back and monitor progress over the 8-week intervention
period. Recent reviews of online digital behaviour change
interventions suggest that the inclusion of human sup-
port increases the efficacy of online interventions [51].
The exercise physiologist will make contact with partici-
pants allocated to the intervention during week one of
the programme (by phone or internet call). They will
discuss participant goals, provide advice about how best
to use the programme to achieve their goals, and offer
remote monitoring of participant progress throughout
the 8 weeks. Remote monitoring will involve reviewing
data entered into the website by participant’s weekly and
providing encouragement, feedback and advice based on
performance. Contact after week one will occur via
email and text messages (up to one per week), with the
exception of week three, which will involve a follow-up
call (by phone or internet). Participants will have the op-
tion of submitting questions to the exercise physiologist
whenever they would like to via ‘the ask the EP’ (exercise
physiologist) feature of the website. Responses will be
sent to participants electronically where possible.
Additional components Library. The Exercise Guide li-
brary is populated with 25 short articles written in lay-
man’s language about different aspects of living with
prostate cancer, exercise and behaviour change. Example
topics include ‘Can exercise help your sexual health?’,
‘Sitting too much: What are the real consequences’ and
‘Exercise and depression: 5 tips to move your mood’.
Diary. A paper-based exercise diary will be provided
to participants in the intervention group to self-report
specific aspects of the resistance training (exercises, sets,
repetitions, session rate of perceived exertion, duration,
Table 2 Modified multimodal exercise prescription for




Upper Trunk Lower WB NWB
Proximal humerus ✓ ✓ ✓ ✓ ✓d
Cervical spine ✓a ✓ ✓ ✓ ✓c
Thoracic spine/ribs ✓a ✓ ✓ ✓ ✓c
Lumbar spine ✓ ✓ ✓ ✓c
Pelvis ✓ ✓ ✓b ✓ ✓c
Proximal femur ✓ ✓ ✓ ✓e
WB weight bearing (walking); NWB non-weight bearing (water
walking; cycling)
✓Target exercise region
aExclusion of shoulder flexion/extension/abduction/adduction—inclusion of
elbow flexion/extension
bExclusion of hip extension/flexion—inclusion of knee extension/flexion
cExclusion of spinal flexion/extension/rotation
dExclusion of elbow flexion/extension
eExclusion of knee flexion/extension
Fig. 4 Example of the video demonstrations provided in Exercise Guide website, (a) standing band row and (b) squat
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bone pain visual analogue score and general pain visual
analogue scale), aerobic training (type, duration, session
rate of perceived exertion, bone pain visual analogue
score and general pain visual analogue scale) and
stretching exercise sessions performed. This will allow
researchers to monitor and report exercise completed,
subjective intensity and any changes in pain levels.
Waitlist control group
Participants randomised into the wait-list control group
will complete the baseline outcome measures as seen in
Table 5 and will then be asked to continue with usual
care, including maintaining their current physical activ-
ity levels for 8 weeks. In week nine, wait-list control par-
ticipants will repeat the outcome measures. At the end
of the intervention, the control group will be sent thera-
bands, given access to the eHealth tool for 8 weeks,
complete two tele-coaching sessions and receive weekly
contact from an exercise physiologist as authors felt it




Trial parameters Screening, recruitment and attrition
rates will all be tracked, with reasons for ineligibility,
lack of interest and drop-out recorded where possible.
Recruitment source will also be assessed during study
enrolment. The proportion of participants with complete
data for each outcome measure will be assessed, along
with the number of reminders and data collection
attempts.
Intervention parameters The time taken to deliver
coaching sessions and respond to questions asked using
the ‘ask and EP feature’ will be recorded in order to pro-
vide a proxy indicator of cost of delivery.
Success of the intervention
Acceptability The acceptability of the intervention will
be assessed using a mixed-methods approach. Partici-
pant’s perceptions of module content will be assessed in
real-time using a five-star rating system (1—poor to 5—
excellent). All other acceptability items will be assessed
in week 9. Perceived personal relevance of website con-
tent will be assessed via survey using three items de-
signed to evaluate the success of tailoring on a 7-point
Likert scale (e.g. ‘the web-based content was written
with someone like me in mind’) [52]. The extent to
which the coaching was perceived as motivationally sup-
portive will be assessed using the 15-item perceived en-
vironmental supportiveness scale [53] and overall
satisfaction with the intervention as a health service will
be assessed using the client satisfaction Questionnaire-8
[34]. Finally, qualitative data will be collecting using
open-ended survey questions and qualitative interviews
Fig. 5 Modified illustrations of the OMNI exercise scale of perceived exertion, (a) resistance training, (b) aerobic training
Table 3 Resistance training prescription
Exercise type Volume of exercise prescribed (sets x repetitions)
Week 1 Week 2 Week 3 Weeks 4-8
Upper body exercises 2 × 12 2 × 12 3 × 12 2-3 × 12-8 (see Additional file 3 for specific prescription)
Trunk exercises 2 × 8 2 × 8 2 × 10 2-3 × 10-12 (see Additional file 3 for specific prescription)
Lower body exercise 2 × 12 2 × 12 3 × 12 2-3 × 12-8 (see Additional file 3 for specific prescription)
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exploring the pros and cons of the website, any unmet
needs, and recommendations for improvement, includ-
ing any suggested changes to intervention length.
Usability Usability of the intervention website will be
assessed using the System Usability Scale [35]. The sur-
vey consists of a 9-item questionnaire with five response
options for respondents ranging from ‘strongly agree’ to
‘strongly disagree’.
Usage Website usage data, including the number of
logins, time on site and number of modules completed,
will be assessed using Google analytics and inbuilt web-
site tracking software [54]. Usage of the exercise diary
will also be recorded in terms of number of sessions
logged.
Adverse events Participants will be advised to report
any injuries either through the website or by calling the
study project coordinator (HE). An item on adverse
events will also be included in the follow-up question-
naire based on the Common Terminology Criteria for
Adverse Events V.5.0 grading criteria.
Behaviour change Accelerometry will be used to ob-
jectively measure weekly minutes of light, moderate and
vigorous physical activity at baseline and immediately
post-intervention. Data will be collected using the Acti-
Graph (ActiGraph GT3X, http://www.theActiGraph.
com) accelerometer, which will be worn on the right hip
during waking hours for 7 days with the intention of
gaining at least 5 days of usable data [54]. Participants
will record times the monitor was removed and wear-
time will be validated using Choi et al. [64]. Triaxial data
will be collected in 1-s epochs along with step counts
and inclinometry. The adapted Godin leisure-time ques-
tionnaire will be used to assess self-reported aerobic and
resistance based physical activity at baseline and imme-
diately post-intervention [12]. Finally, at the immediate
post-intervention follow-up only, self-rated exercise ad-
herence will be measured using two items with an 11-
point numeric rating scale (0 = strongly disagree, 10 =
strongly agree). Participants will be asked to separately
rate their agreement with two statements related to their
adherence to their prescribed programme (overall aer-
obic exercise sessions, overall resistance exercise ses-
sions) [58].
Health outcomes All health-related outcomes will be
assessed at baseline and immediately post-intervention.
Health-related quality of life will be assessed using the
EORTC Quality of Life-Core 30 (EORTC QLQ-C30),
which is a validated and reliable questionnaire for quality
of life in cancer patients [65]. The 30-item core survey
assesses a comprehensive range of quality of life domains
including functioning (physical, role, cognitive, emo-
tional and social), symptoms (fatigue, nausea and vomit-
ing, sleep, pain, appetite, shortness of breath), financial
hardship and global health status [59].
The 13-item Functional Assessment of Chronic Illness
Therapy-fatigue subscale will be administered to meas-
ure participant’s level of fatigue. The questionnaire has
Table 4 Aerobic training prescription for session duration based on participant self-assessment of exercise duration feasibility,
current participation and ability
Duration feasible Meeting duration Ability Aerobic prescription Total active minutes
0-4 min No Low/Higha- 2 × 3-min efforts with 3-5 min rest 6 min
0-4 min Yes Low/Higha 2 × 4-minute efforts with 3-5 min rest 8 min
5-9 min No/yesa Low 2 × 5minutes with 2 min rest 10 min











































3 × 10-min high intensity 30 min
Unknown No/Yesa High/lowa 2-3 × 5-10 min efforts with 2-5 min rest 10-30 min
aPrescription did not differ based on this variable for this prescription
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been demonstrated as a valid and reliable measure [60].
The Hospital Anxiety and Depression Scale will be used
to evaluate changes in anxiety and depression by using
two 7-item Depression and Anxiety sub-scales [61]. The
reliability and validity has been shown to be acceptable
in individuals with prostate cancer [66]. Additionally, the
Pittsburgh Sleep Quality Index questionnaire will meas-
ure sleep quality. Psychometric evaluation of the Pitts-
burgh Sleep Quality Index in cancer patients has
established internal consistency, reliability and construct
validity [62].
Intervention mechanisms
The proposed behavioural change mechanisms will be
assessed at baseline and week 9. This will include
measuring barrier self-efficacy for resistance and aer-
obic activities (9 items [55]), outcome expectations (8
items [67]), motivation type (19 items [56]). Social
support (2 items [55]), intentions (4 items [57]), be-
havioural capability (7 items [52] and habit formation
(4 items [43]). Collection of this data will provide
preliminary insight into if the intervention is working
as expected and will also provide useful information
for directing further tailoring efforts (e.g. by allowing
us to examine how variable individuals are in these
variables at baseline, and thus the extent of tailoring
that is needed). Collection of this information will
also be useful for establishing feasibility of collecting
data needed for a formal mediation analysis in the
main trial.
Table 5 Overview of measurement tools (page 17)








Acceptability Module ratings 10 ✓ x 1-8
Website perceived personal relevance [52] 3 ✓ x 9
Client Satisfaction Questionnaire [34] 8 ✓ x 9
Perceived Environmental Supportiveness Scale [53] 15 ✓ x 9
Qualitative data (open-ended survey questions and qualitative
interview)
4 ✓ x 9
Usability Software usability scale [35] 9 ✓ x 9
Usage Website usage data [54] 3 ✓ x 1-8
Number of exercise sessions 2 ✓ x 1-8
Adverse events Common Terminology Criteria for Adverse Events V.5.0 grading
criteria
1 ✓ ✓ 9
Mechanisms of
action
Self-efficacy [55] 9 ✓ ✓ 0, 9
Outcome expectations [55] 8 ✓ ✓ 0, 9
Motivation type [56] 19 ✓ ✓ 0, 9
Social Support [55] 2 ✓ ✓ 0, 9
Intention [57] 4 ✓ ✓ 0, 9
Behavioural capability [52] 2 ✓ ✓ 0, 9
Habit formation [43] 4 ✓ ✓ 0, 9
Behaviour change ActiGraph Accelerometer [54] 1 ✓ ✓ 0, 9
Modified Godin-Leisure time questionnaire [12] 4 ✓ ✓ 0, 9
Self-rated exercise adherence [58] 2 ✓ x 9
Health outcomes European Organisation for Research and Treatment of Cancer
Quality of Life-Core 30 [59]
30 ✓ ✓ 0, 9
Functional Assessment of Chronic Illness Therapy-fatigue sub-
scale [60]
13 ✓ ✓ 0, 9
Hospital Anxiety and Depression Scale [61] 10 ✓ ✓ 0, 9
The Pittsburgh Sleep Quality Index [62] 14 ✓ ✓ 0, 9
Sub-study physical
function
400m self-paced walk [14] 1 ✓ ✓ 0, 9
Timed up-and-go test [12] 1 ✓ ✓ 0, 9
Repeated chair stand [63] 1 ✓ ✓ 0, 9
One-repetition maximum [14] 2 ✓ ✓ 0, 9
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Sub-study outcome measures
Subgroup selection will be based on proximity to avail-
able testing sites, with all participants (both intervention
and waitlist control groups) who can easily access one of
our testing sites invited to complete subgroup mea-
sures). We intend to have testing sites available in Adel-
aide (the University of Adelaide, University of South
Australia) and Melbourne (University of Melbourne).
Physical function The 400-m walk will be used to as-
sess aerobic fitness level [14, 68]. Participants will be
asked to complete the walk as fast as they complete 20
laps of 20-m track. Measures of completion time (in sec-
onds), maximal heart rate, average heart rate and rate of
perceived exertion will be recorded. The timed up-and-
go test and the repeated chair stand (5 repetitions) will
be measured by time to completion to provide muscular
power, ambulation and functional lower limb strength
[12, 13, 63].
Muscular strength The one-repetition maximum
method will be utilised to determine muscular strength
[14]. The leg extension will be used to determine lower
limb strength, and the chest press will assess upper limb
strength. Patients with proximal femur bone lesions will
be excluded from the leg extension one-repetition max-
imum test, whereas those with rib, thoracic spine lesions
and or humerus lesions will be excluded from the chest
press one-repetition maximum test.
Data management and monitoring
All research data will be stored on a password-protected
network drive on a password-protected computer and
only members of the study team will have access to this
data. Questionnaire data will be recorded using a secure
online data collection instrument (RedCap) with partici-
pants being sent web links at the appropriate time
points. Participant contact information and name will be
held in a separate file to study data, and unique ID num-
bers will be allocated. Only ID numbers will appear
alongside outcome data. A trial steering committee
(CES, DG, GK, NB) will oversee the trial. Any adverse
events will be reported to the committee and the steer-
ing committee have the power the terminate the study if
necessary. As a clinical oncologist and urologist sit on
the trial steering committee, it was determined that a
trial data monitoring committee was not required. Trial
results will be submitted for publication and communi-
cated in a relevant medical or scientific journal.
Data analysis
Sample size
As this is a pilot study, which uses pre-specified criteria
for success rather than a primary outcome, a formal
sample size calculation was not essential [69]. Similar 2-
arm pilot studies have reported sample sizes of 36 and
30 per arm for dichotomous and continuous endpoints,
respectfully [70]. Similar to these studies, the enrolment
target for this trial is 66 participants, 33 in each arm.
Using a sample size calculation method created for pilot
studies by Vichtbauer al., it was determined that the
above sample size will allow us to identify feasibility
problems (drop out, safety issues etc.) with a reasonable
probability of occurring (i.e. a probability of 10% or
greater), with a 95% level of confidence [71]. If issues are
detected the trial team will review and consider if pro-
gression to a larger trial is warranted and feasible.
Study data will be analysed using SPSS version 26
(IBM, Chicago, IL, USA). Descriptive statistics will be
calculated for all study variables. ANCOVAs (or non-
parametric equivalents) will be used to conduct
between-group comparisons, with potential confounders
included in the model (e.g. age, time since diagnosis,
treatment status and baseline outcome assessments).
Treatment effects will be estimated as covariate-adjusted
mean differences between the two treatment groups at
follow up. A senior University of Adelaide statistician
employed by the Freemasons Foundation Centre for
Men’s Health will oversee the analyses. Sensitivity ana-
lyses will be conducted to explore the impact of missing
data and remove any individuals who were unable to be
prescribed with exercise from the analysis.
Qualitative analysis
Any verbal feedback from participants will be recorded
(with permission) and transcribed verbatim. A thematic
assessment will be undertaken to analyse the data as
completed by Braun and Clarke [72]. This approach is
data-driven and involves becoming familiar with the
data, generating initial codes, searching for themes
amongst codes and refining the themes to fit the data
better.
Protocol changes
Future amendments to the protocol will be considered
and approved by the Steering Committee and resubmit-
ted for ethical approval. Approved amendments will be
subsequently distributed to participants through the
study website.
Discussion
The primary objective of the trial is to assess key areas
of uncertainty regarding the use of ExerciseGuide (and
other similar programmes) in future practice and re-
search, including issues relating to feasibility, safety and
potential for efficacy. Publication of this protocol aims
to ensure transparency around pre-specified criterion for
success, aid replication of study and intervention
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methods, and inform interested parties of the upcoming
trial results.
ExerciseGuide represents a novel approach to provid-
ing more geographically accessible individualised exer-
cise prescription with distance-based multidisciplinary
support. The addition of distance-based supervision, tai-
lored behavioural change strategies and telehealth
support, may improve adherence to distance-based inter-
ventions, which are currently seen as inferior in com-
parison to the gold standard ‘face-to-face’ intervention
[23, 29]. Increasing the feeling of personalisation, con-
nectedness, and support through eHealth has been one
method to address the disparity between the two ap-
proaches. It is anticipated that an intervention of this
type would not replace face-to-face interventions, but ra-
ther play a role alongside on-site interventions as an al-
ternative where no onsite interventions can be made
available due to staffing or financial shortages.
Despite the potential advantages, there are a number
of implementation issues that may be encountered when
delivering a programme like ExerciseGuide. These need
to be mitigated in order for high-quality implementation
and evaluation to occur in the future. For example,
whilst the use of eHealth technologies is useful to in-
crease accessibility to individuals in remote areas, it is
important to note that internet connection and reliability
are reduced in remote Australian areas [73]. Our
provision of both written (printable) and video-based ex-
ercise prescription and education may improve access to
those with poor Internet connections; however, those
without a connection will remain without accessible sup-
port. Adherence to health behavioural change and exer-
cise interventions is another limitation noted in the
eHealth literature [26]. We have attempted to improve
adherence by working with consumers to refine content
and by undergoing iterative usability testing in order to
improve the user experience. We have also included ele-
ments of human support which should further enhance
engagement. Lastly, it is well known that recruiting older
males into health interventions is difficult [74]. Numer-
ous different recruitment strategies will be included such
as mass mailing via prostate cancer registries, health ser-
vice referrals and community outreach. Further to this,
advertising materials were gender-specific and mass
mailouts through the prostate cancer registry were per-
sonalised. Data from this trial will provide useful infor-
mation regarding the success of these mitigation
strategies.
Pilot trials studies of this nature can possibly reduce
research waste and more significantly, they can lead to
changes in development and design in order to maxi-
mise the intervention and trial characteristics for future
trials [75]. Usability, acceptability, adverse events, safety,
and evidence of aerobic activity or resistance-based
activity participation will all be monitored to determine
if progression to a full randomised control trial is
worthwhile.
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